KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $3.4.

  • Idexx Laboratories' EPS (Weighted Average and Diluted) rose 2142.86% to $3.4 in Q3 2025 from the same period last year, while for Sep 2025 it was $12.61, marking a year-over-year increase of 2171.81%. This contributed to the annual value of $10.67 for FY2024, which is 601.97% up from last year.
  • Latest data reveals that Idexx Laboratories reported EPS (Weighted Average and Diluted) of $3.4 as of Q3 2025, which was up 2142.86% from $3.63 recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' EPS (Weighted Average and Diluted) registered a high of $3.63 during Q2 2025, and its lowest value of $1.56 during Q2 2022.
  • Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was $2.44 (2024), whereas its average is $2.49.
  • In the last 5 years, Idexx Laboratories' EPS (Weighted Average and Diluted) skyrocketed by 8215.16% in 2021 and then tumbled by 3291.88% in 2022.
  • Idexx Laboratories' EPS (Weighted Average and Diluted) (Quarter) stood at $1.88 in 2021, then increased by 9.56% to $2.06 in 2022, then grew by 12.14% to $2.31 in 2023, then rose by 12.4% to $2.6 in 2024, then skyrocketed by 30.95% to $3.4 in 2025.
  • Its EPS (Weighted Average and Diluted) was $3.4 in Q3 2025, compared to $3.63 in Q2 2025 and $2.96 in Q1 2025.